PSYC Executes Initial Investment into The Conscious Fund
January 21 2021 - 08:30AM
InvestorsHub NewsWire
PSYC Executes Initial Investment into The Conscious
Fund
PSYC Strengthens
Its Position Within the Emerging Psychedelic Sector Through
Investment Into Capital
Fund
LAS VEGAS, NV --
January 21, 2021 -- InvestorsHub NewsWire
-- Global Trac Solutions,
Inc. (OTCPink:
PSYC) (“Global” “PSYC” or the “Company”) a digital media leader
within the emerging sector of medicinal psychedelics, is pleased to
announce that the Company has completed an initial investment
into The Conscious Fund
(the “Fund”), an early-stage venture capital fund focused on the
emerging sector of medicinal
psychedelics.
The investment
represents the first from PSYC of an intended total investment into
The Conscious Fund of roughly $500,000 USD over the next four
years. Furthermore, the Company contends that this investment may
provide PSYC with a very unique opportunity to not only fortify its
positioning within the rapidly expanding industry of medicinal
psychedelics, but also promote the potential for long-term value
for PSYC by connecting it directly to the impressive and diverse
portfolio of psychedelic companies the Fund has
established.
“Over the last
twelve months, The Conscious Fund has done an impressive job of
meticulously assembling one of the most inspiring portfolios of
psychedelic-based companies within the industry,” said David
Flores, Global Trac Solutions, Inc. CEO. “Because of the
diversification and overall potential we see in their portfolio, we
believe our investment into the Fund presents an exciting,
value-driven, opportunity that we expect will not only contribute
to the further development of our industry, but also inspire value
for the shareholders of PSYC over the next several
years.”
The Conscious
Fund’s growing portfolio currently consists of some of the most
prominent up and coming companies within the medicinal psychedelic
sector including: ATAI Life Sciences, Bexson Biomedical,
MagicMed Industries, and CYBIN, and many
more.
"We are
delighted to be working with David and PSYC,” said Henri
Sant-Cassia, Co-Founding Partner for The Conscious Fund. “As the
first public media company in psychedelic medicine, we see huge
strategic value in their investment in The Conscious Fund, and we
look forward to more firsts as the sector
develops."
“Over the past
couple of months, I have spoken about my intent of bringing
diversification back into Global Trac Solutions and positioning the
company on the most reasonable path to success and profitability
possible,” said Flores. “This investment demonstrates my ongoing
commitment to seeing this through while also demonstrating PSYC’s
commitment of establishing itself as a true ally to the emergence
of psychedelics.”
About Global Trac Solutions, Inc.
(OTCPink:
PSYC)
At Global Trac Solutions we are
integrating media, creativity, and technology to develop and deploy
thought-provoking ideas and solutions that are fostering and
transforming the approach to some of society’s most pressing
matters.
PSYC has expressed its intent and
commitment to positioning itself at the forefront of the
psychedelic revolution and as a resource center for discovering and
understanding the latest research and business opportunities
surrounding psychedelic inspired medicines. In conjunction with the
FDA’s more open-minded approach to psychedelic medicines, and as
several major U.S. cities continue to approve the decriminalization
of psilocybin, investors are speculating that the psychedelic boom
could be bigger than that of cannabis. PSYC is your source for
current investment related news specific to psychedelic medicines
and cutting-edge research improving overall health, moving this
sector into the mainstream.
We believe in a forward-thinking
approach that embraces groundbreaking new technology and
innovations and through the vision of business development we
intend to continue to evolve into these unchartered territories as
the industry leaders of the future. We truly are the right TRAC to
follow.
Forward-Looking Statements
Disclaimer:
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors, including the effect of
COVID-19, that may cause our results, levels of activity,
performance or achievements to be materially different from the
information expressed or implied by the forward-looking statements
in this press release. This press release should be considered in
light of all filings of the Company that are disclosed on the OTC
Markets.com website.
Disclaimer: Global Trac
Solutions, Inc. does not in any way encourage or condone the use,
purchase, sale or transfer of any illegal substances, nor do we
encourage or condone partaking in any unlawful activities. We
support a harm reduction approach for the purpose of education and
promoting individual and public safety. If you are choosing to use
psychedelic substances, please do so
responsibly.
Corporate
Contact:
Global Trac Solutions, Inc.
(PSYC)
www.globaltracsolutions.com
(702) 239-1919
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Feb 2024 to Mar 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Mar 2023 to Mar 2024